Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2019 · 10-Q
Revenue$162.97M$162.97M+12.7% vs Q1 2018 Net Income$17.40M$17.40M+9.7% vs Q1 2018 EPS Diluted$0.45$0.45+7.1% vs Q1 2018 Gross Profit$107,603,000+9.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$39,448,000−11.7% Free Cash Flowderived$35,258,000−10.6% Margins · derivedGross margin66.0%−1.6 pt vs Q1 2018
Operating margin15.8%−2.2 pt vs Q1 2018
Net margin10.7%−0.3 pt vs Q1 2018
ended Sep 30, 2018 · filed Nov 7, 2018 · 38 d after period end